We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTD icon
401
Mettler-Toledo International
MTD
$26.8B
$2.48M 0.04%
4,009
-128
-3% -$81.9K
MTB icon
402
M&T Bank
MTB
$36.2B
$2.48M 0.04%
14,528
-739
-5% -$123K
ZGNX
403
DELISTED
Zogenix, Inc.
ZGNX
$2.48M 0.04%
62,000
-105,000
-63% -$4.03M
AKRX
404
DELISTED
Akorn Inc
AKRX
$2.47M 0.04%
76,686
-40,431
-35% -$1.33M
MDCO
405
DELISTED
Medicines Co
MDCO
$2.41M 0.04%
88,000
-14,000
-14% -$431K
HPE icon
406
Hewlett Packard
HPE
$63.2B
$2.38M 0.04%
165,978
+4,267
+3% +$60.6K
ZBRA icon
407
Zebra Technologies
ZBRA
$12.4B
$2.38M 0.04%
22,936
-321
-1% -$34.9K
LUMO
408
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.38M 0.04%
32,556
-3,888
-11% -$322K
CFG icon
409
Citizens Financial Group
CFG
$30.4B
$2.38M 0.04%
56,567
+8,051
+17% +$315K
CDNS icon
410
Cadence Design Systems
CDNS
$90B
$2.37M 0.04%
56,736
-6,009
-10% -$258K
WAT icon
411
Waters Corp
WAT
$36.8B
$2.36M 0.04%
12,222
-873
-7% -$169K
ED icon
412
Consolidated Edison
ED
$41.6B
$2.35M 0.04%
27,620
+2,687
+11% +$231K
SRPT icon
413
Sarepta Therapeutics
SRPT
$1.66B
$2.34M 0.04%
+42,000
New +$2.22M
HBAN icon
414
Huntington Bancshares
HBAN
$35.1B
$2.33M 0.04%
160,185
+28,487
+22% +$400K
ACAD icon
415
Acadia Pharmaceuticals
ACAD
$4.25B
$2.32M 0.04%
77,000
– –
SRRA
416
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.24M 0.04%
+15,000
New +$1.44M
CMS icon
417
CMS Energy
CMS
$23.1B
$2.23M 0.04%
47,033
+741
+2% +$35.9K
TGTX icon
418
TG Therapeutics
TGTX
$8.58B
$2.21M 0.04%
270,000
+50,000
+23% +$437K
ES icon
419
Eversource Energy
ES
$28.2B
$2.2M 0.04%
34,786
+2,329
+7% +$147K
MCK icon
420
McKesson
MCK
$98.5B
$2.16M 0.04%
13,876
-18,106
-57% -$2.68M
BHVN
421
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.16M 0.04%
+80,000
New +$2.2M
NLY icon
422
Annaly Capital Management
NLY
$16.9B
$2.16M 0.04%
45,328
+2,099
+5% +$99.6K
PCRX icon
423
Pacira BioSciences
PCRX
$1.02B
$2.15M 0.04%
47,000
-6,000
-11% -$238K
AGEN
424
Agenus
AGEN
$249M
$2.13M 0.04%
33,372
+1,900
+6% +$145K
MGM icon
425
MGM Resorts International
MGM
$11.7B
$2.12M 0.04%
63,559
+2,654
+4% +$85.5K
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.